Rocket Pharmaceuticals Inc (RCKT) Stock Price, Quote & News

Company Profile

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States. It develops in vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial; Plakophilin-2 Arrhythmogeni...

Industry: Biotechnology

Sector: Healthcare

Phone: 609 659 8001

Website: www.rocketpharma.com

Address:

9 Cedarbrook Drive, Cranbury, United States

Dangerous12 Mar. 21 at 8:03 PM

$RCKT Anyone have BO predictions? Sale price and PPS

2 · Reply

RickyIsRich Mar. 21 at 2:54 PM

$RCKT don’t listen to the troll shorts. We did our research they’ve decided to hop in the past week.

0 · Reply

JD101 Mar. 21 at 1:10 PM

$RCKT Using the full daily history series back to its first trading day, the largest single day close‑to‑close percentage move is approximately +42% on November 4, 2021, when the stock jumped from about 10.6 to 15.1… can we top that

3 · Reply

Resilience1239 Mar. 20 at 11:31 PM

$RCKT quite the volume AH...

1 · Reply

RickyIsRich Mar. 20 at 9:18 PM

$RCKT Not worried orange man causing full market sell off doesn’t change the efficacy this is going to $15

1 · Reply

geegor Mar. 20 at 8:49 PM

$RCKT 🧹🧙‍♀️🧙🏻‍♀️🧙🏾‍♀️🪄 Before getting too excited, remember that today, across the US markets at close, it was a $5.7 Trillion...

2 · Reply

CharlieeMungerTWITS Mar. 20 at 8:48 PM

$RCKT da bleed is a bit disgusting here!!! I made good profit on the run recently but my re buy is average 4.57. Better double babyyyy

1 · Reply

Stephanovich7654568 Mar. 20 at 8:46 PM

$RCKT And the price almost didn't move. 🥰

0 · Reply

HeekLikeThis Mar. 20 at 8:45 PM

$RCKT Don’t worry about the price—within a week it’ll be at $8 or $9. Doesn’t matter if it’s at $4, $3, or even $2 today—the end price will be the same.💚🍀🚀

0 · Reply

Stephanovich7654568 Mar. 20 at 8:44 PM

$RCKT

0 · Reply

Rocket Pharmaceuticals, Inc. (RCKT) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Feb 26, 2026, 4:00 PM EST - 23 days ago

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress

Feb 23, 2026, 7:00 AM EST - 26 days ago

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences

Jan 14, 2026, 5:16 PM EST - 2 months ago

Rocket Pharmaceuticals, Inc. (RCKT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 5, 2026, 7:00 AM EST - 2 months ago

Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 26, 2025, 10:23 AM EST - 3 months ago

Rocket Pharmaceuticals: Deep Dislocation Offers Asymmetric Upside On LAD-I Approval And Amended Danon Program

Nov 25, 2025, 7:00 AM EST - 4 months ago

Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference

Nov 6, 2025, 4:00 PM EST - 4 months ago

Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

Oct 14, 2025, 2:27 PM EDT - 5 months ago

FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy Application Reestablishes Momentum For Stock

Oct 14, 2025, 7:00 AM EDT - 5 months ago

Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)

Oct 10, 2025, 4:00 PM EDT - 5 months ago

Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Oct 3, 2025, 7:11 AM EDT - 6 months ago

Rocket Pharmaceuticals withdraws US application of gene therapy for rare blood disorder

Sep 9, 2025, 12:36 PM EDT - 6 months ago

Rocket Pharmaceuticals, Inc. (RCKT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 20, 2025, 11:02 AM EDT - 7 months ago

Gene Therapy Trial Can Restart After Patient Death, FDA Says. The Sector Remains Depressed.

Aug 20, 2025, 9:31 AM EDT - 7 months ago

FDA Lifts Rocket Pharmaceuticals Study Hold For Rare Disease Gene Therapy

Aug 20, 2025, 7:09 AM EDT - 7 months ago

US FDA lifts clinical hold on Rocket Pharmaceuticals' gene therapy trial

Aug 20, 2025, 7:00 AM EDT - 7 months ago

Rocket Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on the Pivotal Phase 2 Trial of RP-A501 for the Treatment of Danon Disease

Aug 8, 2025, 2:16 PM EDT - 8 months ago

DEADLINE NEXT WEEK: Berger Montague Advises Rocket Pharmaceuticals (NASDAQ: RCKT) Investors to Contact the Firm Before August 11, 2025

Aug 7, 2025, 4:00 PM EDT - 8 months ago

Rocket Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Progress

Jul 30, 2025, 6:29 PM EDT - 8 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 30, 2025, 11:07 AM EDT - 8 months ago

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

CAPR SRPT CABA NGNE NTLA QURE

Jul 29, 2025, 10:26 AM EDT - 8 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 25, 2025, 3:02 PM EDT - 8 months ago

Rocket Refocuses Pipeline As Gene Therapy Sentiment Sours

Jul 24, 2025, 4:02 PM EDT - 8 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Pharmaceuticals, Inc. Lawsuit – RCKT

Jul 24, 2025, 7:00 AM EDT - 8 months ago

Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs

Jul 17, 2025, 7:00 AM EDT - 8 months ago

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A601 Gene Therapy for PKP2-Arrhythmogenic Cardiomyopathy

Jul 11, 2025, 10:25 AM EDT - 9 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 9, 2025, 5:16 PM EDT - 9 months ago

Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Safety Disclosures and Stock Drop

Jul 7, 2025, 9:00 AM EDT - 9 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Lawsuit - RCKT

Jun 30, 2025, 7:00 AM EDT - 9 months ago

Rocket Pharmaceuticals Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy

Dangerous12 Mar. 21 at 8:03 PM

$RCKT Anyone have BO predictions? Sale price and PPS

2 · Reply

RickyIsRich Mar. 21 at 2:54 PM

$RCKT don’t listen to the troll shorts. We did our research they’ve decided to hop in the past week.

0 · Reply

JD101 Mar. 21 at 1:10 PM

3 · Reply

Resilience1239 Mar. 20 at 11:31 PM

$RCKT quite the volume AH...

1 · Reply

RickyIsRich Mar. 20 at 9:18 PM

$RCKT Not worried orange man causing full market sell off doesn’t change the efficacy this is going to $15

1 · Reply

geegor Mar. 20 at 8:49 PM

$RCKT 🧹🧙‍♀️🧙🏻‍♀️🧙🏾‍♀️🪄 Before getting too excited, remember that today, across the US markets at close, it was a $5.7 Trillion...

2 · Reply

CharlieeMungerTWITS Mar. 20 at 8:48 PM

$RCKT da bleed is a bit disgusting here!!! I made good profit on the run recently but my re buy is average 4.57. Better double babyyyy

1 · Reply

Stephanovich7654568 Mar. 20 at 8:46 PM

$RCKT And the price almost didn't move. 🥰

0 · Reply

HeekLikeThis Mar. 20 at 8:45 PM

$RCKT Don’t worry about the price—within a week it’ll be at $8 or $9. Doesn’t matter if it’s at $4, $3, or even $2 today—the end price will be the same.💚🍀🚀

0 · Reply

Stephanovich7654568 Mar. 20 at 8:44 PM

$RCKT

0 · Reply

Stephanovich7654568 Mar. 20 at 8:44 PM

$RCKT Did you sell your share ? Hope not. Did you see the after volume share ??? 3,09 millions of shares !!! This is $13,200,000 millions !!! In 5 minutes !!! We are sitting on a very tight coil spring ! 🥰

1 · Reply

Steve_TheBull_Rogers Mar. 20 at 8:02 PM

$RCKT VIP SUBS This is the new PDUFA in play for next week All will be revealed in this weekends newsletter Not mentioning side or play yet until my VIPs get the full coverage of this one. Will have a full break down of alot of points people on these boards have missed and my full thesis

2 · Reply

Kinderla Mar. 20 at 7:48 PM

$RCKT This price action is not surprising at all. We had a 50% run up until about 10 days ago. What you are searing now is profit taking and de risking leading into the PDUFA. For recent comparison, check out Vanda. VNDA bled out for the coupe of weeks leading into the PDUFA and closed the Friday before slightly under $6. They received approval at a 4pmish the Friday before a Saturday deadline(like RCKT) and quickly shot to $9 in after hours. Will this continue to bleed or will $4.20ish be the bottom? Who knows for sure. I am betting heavily on approval however and I am adding at this level. DYOR, NFA. And good luck!

1 · Reply

Resilience1239 Mar. 20 at 7:34 PM

$RCKT wow, just keep bleeding....

0 · Reply

basssque Mar. 20 at 7:12 PM

$RCKT Added at $4.26

1 · Reply

Diane3825 Mar. 20 at 6:17 PM

$RCKT Man, I have been a biotech watcher (occasional investor) for quite a while and I am so surprised that the share price is not moving up this close to the PDUFA date. The FDA is running mostly on schedule or a little ahead right now so the decision could come any day. Not so say it is a sign or a signal of anything, but it is a little odd to me.

1 · Reply

bobbyhughes611 Mar. 20 at 6:08 PM

$RCKT trying to gather more info on the prv. Is it a guarantee (aka if approved they get it no other outcome) or is there a chance they are approved but denied the prv

5 · Reply

Plowmaster Mar. 20 at 4:25 PM

$RCKT 3/28 PDUFA approaching: • Best-in-class trial data • No efficacy/safety concerns • Prior CRL was manufacturing related • PRV potential adds major value • Validates the broader platform Stock traded $20–$30 in prior cycles. We’re sitting a fraction of that with a binary catalyst weeks away. Risk/reward here is exactly why people invest in biotech.

0 · Reply

Bellz22 Mar. 20 at 2:04 PM

$RCKT this shit better fucking pay off 🤞🏾

1 · Reply

bonghulk Mar. 20 at 1:48 PM

$RCKT All of next week I’m going to be clenching

2 · Reply

nube5779 Mar. 20 at 1:45 PM

$RCKT is up .20! We can all live like kings haha.

0 · Reply

RickyIsRich Mar. 20 at 1:44 PM

$RCKT $12-$15

0 · Reply

Market Cap	485.30M
Revenue (ttm)	0.00
Net Income (ttm)	-223.12M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	11,126,300
Avg Vol	2,743,202
Day's Range	N/A - N/A
Shares Out	108.57M
Stochastic %K	1%
Beta	0.39
Analysts	Sell
Price Target	$8.20